Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-98.99%Free Cash Flow Yield
VS
Market
Sector
Industry
History
$ 5.4Close
$ 1.02 - $ 5.63 52-Week Range
Ticker Information
Ticker
ENTOCompany Name
ENTERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTERO THERAPEUTICS INC - Free Cash Flow Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTO - FCF Yield Historical data
| Date | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
|---|---|---|---|
| 6/30/2025 | $ -2.89M | -98.99% | $ 2.92M |
| 3/31/2025 | $ -6.29M | -306.92% | $ 2.05M |
| 12/31/2024 | $ -9.22M | -471.75% | $ 1.95M |
| 9/30/2024 | $ -12.49M | -416.88% | $ 3M |
| 6/30/2024 | $ -13.97M | -432.09% | $ 3.23M |
| 3/31/2024 | $ -13.28M | -180.65% | $ 7.35M |
| 12/31/2023 | $ -12.38M | -139.54% | $ 8.87M |
| 9/30/2023 | $ -14.53M | -387.18% | $ 3.75M |
| 6/30/2023 | $ -15.45M | -511.53% | $ 3.02M |
| 3/31/2023 | $ -17.28M | -343.91% | $ 5.02M |
Key Performance Insights, Last 5 Years
- ENTERO THERAPEUTICS INC's latest trailing twelve months (TTM) FCF Yield stands at -40.28%.
- Over the past 5 years, ENTERO THERAPEUTICS INC's average FCF Yield has been -276.87%.
- The median FCF Yield for ENTERO THERAPEUTICS INC during this period was -325.41%
- ENTERO THERAPEUTICS INC reached its highest FCF Yield over the past 5 years at -11.16%.
- The lowest FCF Yield recorded by ENTERO THERAPEUTICS INC in the same timeframe -511.53%
Similar metrics to Market Cap:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
Definition of Free Cash Flow Yield
[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.FCF / Market Cap
(=) FCF Yield FCF Yield for ENTERO THERAPEUTICS INC is calculated as follows: FCF [ $ -8.57M ] / Market Cap [ $ 21.27M ]
(=) FCF Yield [ -40.28% ] ENTO - Free Cash Flow Yield, Last 5 years
-511.53%
Minimum
Jun 30, 2023
-11.16%
Maximum
Dec 31, 2020
-276.87%
Average
-325.41%
Median
FCF Yield Benchmark AnalysisMarket
The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.62% with a standard deviation of 11.35%.
The following table provides additional summary stats:
FCF Yield in the Market:
| filtered constituents | 3.58K |
|---|---|
| min | -33.87% |
| max | 37.55% |
| average | 1.62% |
| median | 3.25% |
| std | 11.35% |